Philip Morris
Risk Assessment for Carcinogens: A Comparison of Approaches of the Acgih and the Epa
Fields
- Author
- Alavanja, Mcr
- Brown, C.
- Gomez, M.
- Spirtas, R.
- Brown, C.
- Area
- LOGUE,MAYADA/OFFICE
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- DRAW, DRAWING
- BIBL, BIBLIOGRAPHY
- Site
- N426
- Named Organization
- Acgih, American Conference of Governmental Industrial Hygienists
- Epa, Environmental Protection Agency
- Request
- Stmn/R1-072
- Document File
- 2025545619/2025546382/Harvard University Office of
- Continuing Education Short Course Program Harvard School
- of Public Health
- Continuing Education Short Course Program Harvard School
- Master ID
- 2025545673/6381
Related Documents:- 2025545673-6381 Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025545684 Telephone Locations and Protocol
- 2025545697 Hps Newsletter Interview with A Risk Expert
- 2025545698-5711 Science and Its Limits: the Regulator's Dilemma
- 2025545713-5721 Risk / Benefit Analysis
- 2025545722-5725 Risk Management Commentary for Dr. D. Allan Bromley Assistant to the President for Science and Technology
- 2025545726-5729 Risk Assessment and Comparisons: An Introduction
- 2025545750-5792 Risk Assessment of Chemical Carcinogens: Is It Time for A Change?
- 2025545795-5799 Tools of Risk Analysis Applications of Epidemiology
- 2025545800-5810 Notice of Intended Changes - Benzene
- 2025545811-5822 Epidemiology in Risk Assessment for Regulatory Policy
- 2025545824-5850 Risk Analysis in Environmental and Occupational Health Use of Animal and Other Data As Predictors of Human Risk
- 2025545851-5871 Risk Analysis in Environmental and Occupational Health Uncertainties in Predicting Human Risks
- 2025545872-5881 How Do Cancer Risks Predicted From Animal Bioassays Compare with the Epidemiologic Evidence? the Case of Ethylene Dibromide
- 2025545882-5887 Use of Biological Assays in Short-Term Assessment of Inhaled Substances
- 2025545888
- 2025545889-5891 Risk Analysis in Environmental and Occupational Health Are Your Mushrooms Safe to Eat?
- 2025545892-5899 the Rat As An Experimental Animal
- 2025545901-5907 Non-Cancer Endpoints
- 2025545910-5939 Cancer Facts & Figures - 890000
- 2025545940-5941 Cancer Facts & Figures - 890000
- 2025545942-5944 Get - the - Lead - Out Guru Challenged A Decade-Old Scientific Argument Over the Effects of Low-Level Lead on Iq Turns Nasty Following Allegations of Misconduct
- 2025545945-5948
- 2025545949-5958 the Question of Thresholds for Radiation and Chemical Carcinogenesis
- 2025545959-5980 Are There Thresholds for Carcinogenesis? the Thorny Problem of Low-Level Exposure
- 2025545981-5990 Perspectives on Comparing Risks of Environmental Carcinogens
- 2025545991-5998 Acceptable Cancer Risks: Probabilities and Beyond
- 2025546000-6011 Ideas in Pathology Pivotal Role of Increased Cell Proliferation in Human Carcinogenesis
- 2025546012-6017 Cell Proliferation in Carcinogenesis
- 2025546019-6027 the Role of Expert Judgement in Risk Analysis
- 2025546029-6039 the Respiratory Tract As A Route of Exposure
- 2025546040-6045 the Respiratory Tract As A Portal of Entry for Toxic Particles
- 2025546047-6062 Limitations to the Use of Employee Exposure Data on Air Contaminants in Epidemiologic Studies
- 2025546063-6083 Benefit - Cost Analysis of Environmental Regulation: Case Studies of Hazardous Air Pollutants
- 2025546086-6089 Legislative and Regulatory Aspects of Risk
- 2025546090-6099 Connecticut's Dioxin Ambient Air Quality Standard
- 2025546100-6103
- 2025546105 Annals of Radiation Calamity on Meadow Street
- 2025546106 Caution Urged When Using Insect Repellents
- 2025546116 Volatile Organics and Inorganics Action Levels 900400
- 2025546134-6135 Summary of Radon Test Results of the Household Testing Program
- 2025546141-6145 Introduction to Discussion Sessions
- 2025546146-6149 Risk Assessment in Environmental and Occupational Health Risk of Alar (Daminozide)
- 2025546150-6160 Intolerable Risk: Pesticides in Our Children's Food
- 2025546161-6162 Pesticides, Risk, and Applesauce
- 2025546163-6168 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546169 Daminozide / Udmh
- 2025546170-6172 the Relative Risk of Daminozide (Alar / Kylar) Use
- 2025546173 Be Most Wary of Nature's Own Pesticides
- 2025546174-6175 A Movie Star Pares the Apple Industry
- 2025546176-6183 Summary of Toxicology Data on Daminozide and Udmh
- 2025546184-6194 Attachment I Graphs of Data From NCI / Ntp 83 Daminozide
- 2025546195-6196
- 2025546197-6202 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546203-6224 Regulatory Decision - Making Under Uncertainty: the Case of Alar
- 2025546226 Epa Moves to Reassess the Risk of Dioxin Urged on by the Scientific Community, Epa Is Developing A New Model for Estimating Dioxin's Risk
- 2025546227 US Government Orders New Look at Dioxin the Environmental Protection Agency Is Evaluating Data From the Past Decade That Suggest Dioxin's Toxicity May Be Overestimated. A Risk Assessment Model Based on Biological Mechanism Is Being Drawn Up.
- 2025546228-6235 Dioxin Toxicity: New Studies Prompt Debate, Regulatory Action New Data on Dioxin's Effect on Humans, A Clearer Picture of the Cellular Events It Precipitates, and New Animal Toxicity Studies May Provide Epa with A Firm Basis for Regulation
- 2025546236-6250 the Regulation of Gene Expression by 2,3,7, 8-Tetrachlorodibenzo-P-Dioxin
- 2025546251-6253 Dioxin Risks Revisited Armed with A New Understanding of How Dioxin Works on the Molecular Level, A Number of Scientists Are Challenging Epa to Change the Way It Does Risk Assessment
- 2025546255-6258 Lead Toxicity Case Study for Short Course on Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025546259-6267 Lead
- 2025546268-6275 Lead in Bone: Implications for Toxicology During Pregnancy and Lactation
- 2025546276-6281 the Long-Term Effects of Exposure to Low Doses of Lead in Childhood An 11 - Year Follow-Up Report
- 2025546282-6285
- 2025546298-6321 Review 890000 Alice Hamilton Lecture Lead and Human Health:Background and Recent Findings
- 2025546323-6348 Traps and Errors in Risk Analysis
- 2025546349-6356 Health Risks the Perception of Reality and the Realty of Perception
- 2025546357-6362 Communicating Risk Under Title III of Sara: Strategies for Explaining Very Small Risks in A Community Context
- 2025546363-6368 Industrial Risk Perceptions
- 2025546369-6370 Too Many Rodent Carcinogens: Mitogenesis Increases Mutagenesis
- 2025546371-6373 Has Risk Assessment Become Too 'conservative'?
- 2025546374-6378 Health and Safety Risk Analyses: Information for Better Decisions
- 2025546379-6381 Telling Reporters About Risk Dealing with Reporters Needn't Be the Least Agreeable Part of the Job.
- Author (Organization)
- Natl Inst of Child Health + Human Develo
- NCI, Natl Cancer Inst
- Acgih Chemical Substances Threshold Limi
- Appl Occup Environ Hyg
- Biostatistical Methodology + Cancer Cont
- Division of Cancer Etiology
- Division of Cancer Prevention + Control
- NCI, Natl Cancer Inst
- Litigation
- Stmn/Produced
- Characteristic
- EXTR, EXTRA
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- ujp02a00
Document Images
Risk Assessment for Carcinogens: A
Cornparison of Approaches of the ACGIH
and the EPA
Michael C.R. Alavanja,A Charles Brown,8 Robert Spirtas,1-D and Manuel Gomez"
AEpiderniology and Biostatistics Program, Division of Cancer Etiology, National Cancer Institute,
Executive Plaza
North ® uilding, Room 543, Bethesda, Maryland 20892; BBiostatistical Methodology and Cancer Control
Epidemiology Section, Division of Cancer Prevention and Control, National Cancer Institute,
Executive Plaza
North Building, Room 344, Bethesda, Maryland 20892; cNational Institute of Child Health and Human
DeveH)pment, Executive Plaza North Building, Room f07, Bethesda, Maryland 20892; °Mernber of the
Americzu1 Conference of Governmental Industrial Hygienists' Chemical Substances Threshold Lin'it
Values
Committee
The rel ative carcinogenic potency of 16 chemicals evaluated
by both the U.S. Environmental Protection Agency (EPA) and
the Chemdcal Substances Threshold Limit Values (CS-TLV) Com-
mittee of the American Conference of Governmental Industrial
Hygienista, (ACGIH) were compared. The estimated cancer risk
resulting from occupational exposure to the threshold limit values
(TLVs) were also computed using dose-response curves devel-
oped as a part of EPA quantitative risk assessments.
Subst:untial agreement between the EPA and the CS-TLV Com-
mittee was found when the relative potency of these carcinogens
was compared. Use of EPA's risk model to estimate lifetime
cancer risk from occupationall exposure at the TLV levels often
resulted in high cancer risk estimates. The approaches used to
assess cancer risk by both groups is described and a suggestion
is made i~oir incorporaring existing quantitative risk assessments
into the IjLV evaluation procedure. AlStla* M.C.R.; BroMfft, C.;
Spirtas, R.; hmez, lbl.: Risit Ameststent for Carctrogem A foffoarison
of Approa%es of 4he ACG}9 and tbe F.PII. Appi. Occup. Erwrwt. Ftyg.
5:510-51 7; 1990.
Introducrtiion
The Chemical Substances Threshold Limit Values (CS-
TLV) Committee of the American Conference of Govern-
mental Industrial Hygienists (ACGIH) has been reviewing
its policie.s and procedures regarding carcinogens. Spirtas
et al. (1985) described the current process the CS-TLV
Committee uses to make the qualitative decision to des-
ignate a chemical as a workplace carcinogen and the quan-
titative decision to recommend levels of exposure for the
guidance of industrial hygienists.0) Threshold limit values
(TLVs) (for carcinogens as well as other toxic agents) are
time-weighted averages (TWAs) for a normal 8-hour work-
day, 40-hour workweek. The TLV is set for inhalation ex-
posure, with special notifications for agents where ab-
sorption from skin exposure is important. The TLV is
assumed to be protective for "nearly all workers" assuming
the workers to be healthy adults <') TLVs are guidelines
for good work practices to be used only by professional
industrial hygienists. For substances which cause chronic
diseases such as cancer, however, there may not be a sharp
cutoff point (threshold) between effect and no effect; it is,
therefore, important that professional judgment be used
in monitoring and protecting workers exposed to such
substances.
When deciding on guidelines for carcinogens, the CS-
TLV Committee gives greatest weight: to epidemiologic
studies having data onn quantitative exposure levels.<' ) Such
substances receive an Al categorir.aion and are calied
"Confirmed Human Cardnogens:'IVext in importance, and
more typically available, are mamn>alnn toxicologic stud-
ies having whole-bocty bioasstys. Such %Aam= are given
an A2 designation and are called "Suspected Human Car-
cinogens:" In reviewing the key experimental toxicology
studies, the Committee considers route of entry (greatest
weight given to inhalation studies), dose-response gra-
dient, potency, mechanism of action, <2ncer site, time-to-
tumor, length of exposure, and underiyi.ng incidence rate
for the type of cancer and species under study. Replication
of results is important, especialty if eomparable in different
species. Other types of studies are useful in confirming
Thiti article representti the views of the authors aad not tfiose of the
Americui Ccxiference of Governmental InKlustrial Hygienists or its Chetn-
ical tiutwances Threshold Limit Values Committee, or those of ttie U.S.
De}rartment of Health and Human Services, the Natiotnl ir>stitutes of
Health, and the National Carxer Institute
510 APPL OCCUP. pYYHiONI. NY& 50 AU6lSSi 1le0

that a substance is a carcinogen but are no* usually helpfu!
in setting a TLV. A safety factor is often applied to estabiisE;
a TLV for carcinogens, by taking the lowest level known
to induct cancer (or the no-effect level) and then dividing
that hv in arbitrarv factor, such as 10 or 100. The CS-TLV
C;ommittee. realizing the imprecision of setting TLV,, for
carcinogtn.ti. recommends that. for all carcinogens having
a TlY. "worker exposure by all routes should he carefully
controlled to levels as low as reasonably achievable (A1ARA)
below the TLV:"')
In the earlv 1970s, the U.S. Environmental Frotection
Agency (EPA) developed an approach that wa5 different
from that of the CS-TLV Committee. Early decisions by the
EPA conveyed the idea that the only acceptable degree of
regulation of carcinogens would be a total ban on expo-
sures.(3.") However, the impracticality of achieving zero
risk on a broad scale for a large number of economically
important chemicals became increasingly apparent to many,
including die U.S. Congress. As a result, the EPA in 1976
became the first federal agency to adopt formal guidelines
embracing a two-step process of risk assessment. The first
step is a determination of whether a particular substance
constitutes a cancer risk, i.e., hazard identification. The
second step includes a quantitative risk assessment (QRA)
as a key component of determining the degree of regu-
latory action needed to protect the publict5~
- As part of the QRA process, the EPA computes dose-
response curves, makes low-dose extrapolations, and es-
timates the size and degree of exposure of the exposed
populations in order to estimate the number of excess
cancers exp~cted in the total U.S. population. The rationale
and procedures for the EPA approach are used to guide
regulatory actions which are meant to protect each mem-
ber of the general public over a lifetime against exposure
via inhalation or ingestion.(6) Regulatory action is taken
only after the results of the QRA are integrated with en-
gineering data and with social, economic, and political
concerns.C>
Confusion-has arisen from the different approaches used
by the CS-TI V Committee and the EPA in estimating risk
Although tihe TLVs continue to be used widely by profes-
sional industrial hygienists around the world to evaluate
the safety of workplace exposures, the QRA approach is
viewed by some as riore objective. Recently, criticism of
TLVs has focused attention on the objectivity and scientific
standards of the CS-TLV Committee.ts> Several examples
were given of chemical substances for which unpublished
data (primarily from the files of industrial companies) were
important in setting the recommended TLV. Since, in many
instances, the TLV is the only number available to industrial
hygienists, it is important that the CS-TLV Committee's pol-
icies and procedures regarding carcinogens be reviewed
to assess the results of the current TLV approach. We be-
lieve a quani:itative comparison of the EPA and the TLV
approaches may provide some important information re-
garding thi.; assessment.
Reflecting on some of these issues, Andersent9> pre-
sented a critical review of quantitative risk assessment in
occupational health in the 1988 Herbert E. Stokinger Lec-
ture, concluding that, "Quantitative Risk ASSessment is not
just coming to the occupational environment. It is here
now and is an issue to be reckoned with by everyone of
us in the industrial hygiene profession"") in his review,
Andersen suggetits that QRA during the past 13 years has
been "damned" hv its misapplication. Overly conservative
quantitative approaches to predicting risk would lead to
risk estimates that "greatly restrict commercial operations,
decrease our ability to compete in world markets, and lead
to large expenditures to change work practices with no
concomitant increase in health protection:' He went on to
suggest that the problems faced by the use of overly con-
servative techniques can be overcome in part by the use
of recent cancer models that have greater biological rel-
evance, e.g., the physiologically based pharmacokinetics
models (PB-PK)t10> and the Moolgavkar, Venzon, Knudson
(MVK) models.t t t> Although the theoretical appeal of these
cancer models is clear, the bulk of the QRAs developed
and published since 1976 have come from regulatory agen-
cies which have not used these new techniques. We cannot
compare current TLVs to the results of risk assessments
using the MVK or PB-PK approaches; however, comparing
established TLVs for carcinogens with the results of the
EPA QRAs may help determine whether, and under what
circumstances, the CS-TLV Committee may consider using
QRAs as part of its decision-making process. This article
presents a comparison between the ACGIH TLVs and the
EPA QRAs for the 16 chemical carcinogens that have been
evaluated by both groups. These QRAs were chosen for
comparison since they are the largest available collection
of risk as.5essment5 developed by a standard methodologic
approach.
f
ARedods 8etd Reaults
The comparison reported herz is derived from the ACGIH
1988-1989 list of'II.Vst12) and an EPA list of carcinogens
taken from the Integrated Risk Information System.t13)'Itie
ACGIH list contains over 700 agents of which 55 are clas-
sified by the Committee as carcinogens in the adopted list
plus 3 in the Notice of Intended Chznges List. These 55
substances are listed along with their TLVs, where available,
in Table I. The EPA list, in Table II, oontains 54 agents,
including a substantial number of pesticides and nitrosa-
mines for which a unit risk factor fbr inhalation exposure
is available. The EPA's unit risk factor is a conservatively
estimated risk to humans from constant lifetime exposure
of breathing contaminated air at a level of 1 µggm3. This
risk estimate is derived from the availabL- results of animal
bioassays, biochemical studies, and epidemiologic studies.
To assure safety, conservative assumpaons are used to sup-
plement missing or unknown information (e.g-, using re-
sults from the most sensitive animal species and the lin-
earized multistage dose-response model and extrapolaring
using the upper 95 percent confidence limit of the ex-
perimental evidence).
The ACGIH TLVs are compared with the EPA QRAs
APPL OCCUP. ENb7RON. 1fYG. 50 AUGUST 1990 511

TABLE L_CPtemicaf Substances Classified as Carciragens by I4C6M1 witth Tfieir Respective TtVs
(1988-1989 Adopted YaNye.s)
Substance TLV I Subsfanca TLV
Acrylamide-Skin" 0.03 rnqhrr' Ethylene dibromide-Skin -
Acrylonitrile--Skin^ 4.5 mg/m3 Ethytene oxide" 1.8 mglm3
4-Aminodiphynyl-Skin e Formaldehyde" 1.5 mg m'
Antimony triouide production Hexachforobutadiene-Skin" 0.21 mghrrj
Arsenic trioxice production Hexamethyl phosphoramide-Skin -
Asbestos Hydrazine-Skin 0.13 mg/m'
Amosite 0.5 fiber/cc 4,4'-Methylene bis(2-chloroaniline)-Skin 0.22 mg/m3
Chrysotile 2 fibers/cc Methylene chloride (Dichloromethane)" 175 mg/rn3
CrocidoliCe 0.2 fiber/cc 4,4'-Methylene dianiline 0.81 nxyrrt3
Other fonns 2 fiberslcc Methyf hydrdzine---Skin 0.35 nxynr3
Benzene' 32 mg/m3 Methyl iodide-Skin 12 mg/n~
Benzidine-Sk:n B P-Naphthylarnine B
Benzo(a)pyrene - Nicked sulfide roasting, furne & dust 1 mWm', as Ni
BeryfliurM 0.002 mgm3 4-Nitrodiphenyt ®
1,3-Butadierk'A 22 rig(mrl 2-Nitropropane 35 mg(m3
Carbon tetrachloride-Skin" 31 mg/rn3 N-Nitrosodimethybmine--Skin
Chloroform" 49 mcym3 N-Pherryl ~pt~r}2mir~e
bis-(ChtoronMethyf)eW 0.005 mghrr3 Ptery4trydrazine-Skin 22 mgrm'
Chlomiethyf r*fryf ethes - PrOpane sJlforle -
Chromates of Is3d, as Cr 0.05 rtxyrtrj P-PrombcWt 1.5 mg+m'
Chromite ore pnxessin0 (chromate) 0.05 m{ynP, as Cr Propylene imine-51dn 4.7 mgW
Chromium (Y), certain water insoluble compouro 0.05 nxym;, as Cr o-Totidine-Sfdn -
Chrysene - o-Toluidine--Skin 9 MgVm'
Coal tar pitch velaCGfes 02 rrKym3, as bentene p-Toluidins---Skin 9 RWTP
solubles Vinyl bromide 22 rnPP
3,3'-Dichforotenadine--Skin Ynyf dtrotide 13 mom'
Dimethyl carlkunlyl chloride Vrryi *Wmerie 6WAe-_%n 57 mg/rn3
1,1-Dirnethyftdrazine--Skin 12 mg/rr-P Zinc dvoirraft 0.01mgim3,asCr
Dimethyf sulfale--Skin 0.5 mg(nr3
_ Ploticce o( kftXW OWN)es ('Oor 1985-1999)
Cadmium and canpocmds" 0.1 mgirna Etlry1 wY& 20 mglm3 Xytidine (nroW isorr~rs}- Skin 25 mglrts'
"(3t~emiqls corKainEd on both Ux TLV and EPA rardnogen IisL
BSubstance desigried by CS-TLV Cartmittee as a confimred txman caraaogen wftait a nV. Wa4ds oTosed
bfia arbslarxe should be `popey equiav~d n vfrYaMy d;ma;* ap oPOMue ~
in two ways: 1) do the ACGIH and EPA place these
chemicals in the same order of toxicity? and 2) what level
of risk do tf, e EPA unit risk factors imply from exposure
to the ACGIH's TLVs? The EPA dose-response assessment
commonly begins with the multistage model,
P(d) = I -- exp(qid + q2d2 + . .. + qkdk),
puts an upjD<!r 95 percent confidence limit on the linear
term of the dase-response (qIs) based on a sratistical eeal-
uacion of anitnal bioassay data (with consideration of spe-
cies, route of administration, duration of exposure and
followup, and other experimental design criteria deemed
most relevantt to human risk assessment), and then uses
the linearized multistage model (only the linear term is
included) to estimate the risk of lifetime exposure to low
doses. Bera,uLq.e the linearized multistage model used by
the EPA for its unit risk Pactor is equivalent to the single
hit model, our estimate of lifetime risk of developing can-
cer from occupational exposure is based on the model,
Prob (d) = 1 - exp(-ad),
where Prob(d) is the lifetime probability of developing
cancer from exposure to a daily level of d µg/m3 during
a working lifetime of a 40-hour workweek/168-hour week,
a 50-week/workyear, a 40-year career, and an average life
span of 74 years. The slope of this dose-response curve
(a) directly indicates cancer risk, thus a larger slope im-
plies a larger risk at the same dose. The slope is derived
from the EPA unit risk factor and is adjusted as follows to
reflect different exposure situations.
To adjust for different exposure durations, we use the
simple assumption ti= the dose-response slope for oc-
cupational exposure is (40/168) x(50/52) x(40/
74) = 0.124 of the complete lifetime exposure slope. The
EPA assumes a normal respit:gion rate of 20 cubic meters
in a 24-hour period white sm assume a r2te of 10 cubic
meters in an 8-l~our avurking day. Ttyerefcxe, to adjust for
different breathing rates for working and nonworking per-
sons, we assume the occupational exposure slope is
(10/8)/(20r24) = 1.5 times the EPAA slope.
Figure 1 displays the comparison of the ACGIH and EPA
arrangements of the 16 common agents in decreasing or-
der of risk (increasing TLV level and decreasing unit risk
order). The spearman rank eorrelation coefficient for these
two orderings is r = 0.78 implying substantial, yet im-
perfect, agreement. The major disagreements are the or-
derings of hexachlorobutadiene,l,3-butadiene, vinyl chlo-
ride, formaldehyde, 'and chloroform. The ACGIH has
hexachlorobutadiene with a greater carcinogenic risk than
1,3-butadiene, and vinyl chloride with a greater risk than
512 APPL OCCt1P. &VNROAb M'6. SfN AUBUSi i!!0

chloroform, while the EPA reverses this order. In addition,
ti>rmaldehycie is substantially higher on the ordering by
ACGIII than by EPA. In establishing TLVs for vinyl chloride
and chloroform, the C5-TLV Committee probably weig'.ited
heavily the positive epidemiologic evidence for vimyl chlo-
ride, in deciding to establish a relatively more protective
value for vinyl chloride than for chloroform. The TLV for
formaldehyde is based primarily on prevention of eye,
nc>se. and tl roat irritation. These acute effects have been
ohserved in humans at levels below the lowest effect seen
for carcinogenicity in rodents. The discrepancy for 1,3-
buradiene rin be explained, in part, by the CS-TLV Com-
mittee minimizing the relevance of an animal bioassay
which induced angiosarcomas of the heart, a rare tumor
in humans. '
Table III gives the TLVs and adjusted unit risk for these
agents along with the EPA's estimate of daily occupational
exposure h---,els corresponding to lifetime cancer risks of
one in a million and one in a thousand. This table also
gives an eitimate of the lifetime risk from occupational
exposure to a daily level at the TLV. Eight of these 16
estimated lifi>time cancer risks from occupational expo-
sure to the TI1,V lie between 1 and 10 percent with the two
highest estimates being chloroform at 19 percent and 1,3-
hutadiene at 158 percent while the two lowest estimates are
he.Y:.tchlorobutadiene at 0.1 percent and beryllium at 0.09
percent. On the average, the TLVs for these 16 agents are
over 25 tiree,, greater than the EPA estimated daily expo-
sure level ~is;;ocia¢ed with a risk of 1/1000. Table III also
Tl. v Order
Beryllium
B is(chloromethyl )ether
Cadmium
Acrylamide
Chromium VI
Hexachlorobutadiene
Nickel Refinery Dust
Ethylene Oxide
Acrylonitrile
Vinyl Chloride
1,3 Butadiene
Benzene
Carbon Tetrachloride
Chloroform
V
Formaldehyde
Benzene
Vut--yI Chloride
I Methylene Chloride et y erte on e,
RM 1. Ordering of chemicals by estimated risk by the Chemical Sub-
stances TLV Committee and the U.S. Environrttertal Proiecfion Agency.
TABLE ll. C#ttmicals Catdnwgens for Which QuaciftOM RiSIcs Fare Been 0
Group for httalabon 6tpo:are by U.S al1's CsrraaoyAn AnewrorE
Compour>ds Unii Risit Factors' CUMMEXIS Uait Risit FsdoPS`
_
Acetaldehyde 22x10-6 12-Dipt>erryttt}rdrarirte 4.5 x 10-t
Acrylamide 1.3x10-3 Epid>lorohydrin 12 x 10-6
Acrylonitrile 6.8 x 1U-5 Ethylene oxide 1.8 x 10-2
Aldrin 4.9x10-3 Fomlaldefrytie 1.1 x iU-'
Arsenic 4.3 x 10-3 Heptactda 1.3x10-3
Asbestos 2-3 x 10-1 H"chlor Ma" 26x10-3
Azobenzene 3.1 x 1o--5 Nexadtlorobutadiene 22 x 10-5
Benzene 8.3 x 10-6 Headtbrocyclohmrte 21 x tUs
Betuidene 6.7 x 10-z Whnical Wade 2.0 x 10-r
Beryllium 2.4 x 10-3 alpha ison>et 1.8 x 1(F3
1,3-Butadierte 28 x 10-4 befa isomw 5.3x1Q-'
Cadmium 1.8 x 10-3 Hexisch1otod+bqizoftxirt 1.3 x 104
Carbon tetrachloride 1.5 x 10-5 tiytbatirtPhtyd~aatte srtffale 4.9 x 10-3
Chlordate 3.7x10-5 Nidtei ref'urery dusi 24x10-4
bis(2-cttloroeih!(I)~tter 3.3x10-' Nir,lei sulwtfide 4.8x10-4
Chloroform 2.3 x 10-5 NiVoso-dim~e 1.4x10-2
bis(chlorometh}l)Eltter 62x10-2 Di-bt4yiamirte 1.6x10-'
Chromium VI 12 x 1D-z Dewftsam4* 43x10-z
DDT 9.7 x 10-s N-rtitrosopysrolidMe 6.1 x 10-4
1,2-Dibromoettlan, 22 x 10-t 2-Tehactdaoetttane
1,1,1 7.4 x 10;
Dibutylnitrosamir>E, 1.6 x 10-3 ,
22-Tetrathloroefhane
1
1 5.8x10-s
1,2-Dichloroeft>itrH: 26 x 10-s ,
,
Toxaphene 32x1o-4
1,1-Dithloroett>ulene (Vinylidene chloride) 5.0x10-5 1,1,2-Tricttloroettlarte 1.6 x 10-5
DichlorometharNS (Methylene chloride) 4.1 x 10-6 Tridtioroethyfene 13 x 104
Dieldrin 4.6 x 10-3 2,4,6-Trichloropt>enoi 5.7x10-6
Diethylnibosamine 4.3 x 10-2 Vinyl chloride 7.1 x 1Q-i
Dimethylnitrosarnine 1.4 x 1U-2
`Eslimafed risk !o hunws from consW lifetime evwe ol txeatMrg cordamirgted air at a IeveM ot i
µryrnd.
EPA Order
Bis(chloromethyl)ether
Chromium VI
Beryllium
Cadmium
Acrylamide
1,3 Butadiene
Nickel Refinery Dust
Ethylene Oxide
Acrylotritrile
Chloroform
Hexachlorobutadiene
Carbon Tetrachloride
APPL OCCUP. ENVIRON. HYG. 50 AUGUST 19911 513

TABLE 111. Estimated Lifetime Cancef R6sh from Ocmpafionaf ExpoSVre to the TLV
IARC
TLV
Adjusted Daify Expsure (µg/m')
Assaciated with Risk of Estirrtated Life6me
Carrcer Risk from
Substance Class µg/V Unit Risk' 1/10' 1/101 ExQostrre to TLV
Acry)arnide 28 30 2.4 x 10-' 4.2 x 10-; 4.2 0.0072
Acrylonitrile 2A 4500 1.3 x 10-5 7.7 x 10-z 7.7 x 10' 0.057
Benzene 1 30000 1.5 x 10-6 6.7 x 10-' 6.7 x 102 0.044
Beryllium 2A 2 4.5 x 10-' 2.2 x 10-' 2.2 0.0009
1,3-Butadiene 28 22000 5.2 x 10-5 1.9 x 10-2 1.9 x 10' 0.68
Cadmium 2A 10 3.3 x 10-' 3.0 x 10-3 3.0 0.0033
Carbon tetrachloride 2B 30000 2.8 x 10-6 3.6 x 10-' 3.6 x 102 0.081
Chloroform 213 50000 4.3 x 10-b 2.3x10-' 23x102 0.19
bis(Chlorometltyl)e~ 1 5 1.2 x 10-2 8.3 x 10-5 8.3 x 10-z 0.058
Chromium (VI) 1 50 2.2 x 10-3 4.5 x 10-* 4.5 x 10-' 0.10
Dichloromethane 2B 175000 7.6 x 10-' 1.3 1.3 x 103 0.12
(M4etiiylene chloride)
Ethylane oxide
2A
2000
2.0 x 10-5
5.0x10-z
5.0x10'
0.039
Famnalde?* 2A 1500 2.4 x 10-6 4.2 x 10-' 4.2 x 102 0.0036
Hexachlorobuhadierre 3 240 4.1 x 10-6 2.4 x 10-' 2.4 x 102 0.00098
fdickel refinery dusf 1 1000 4.5 x 10-5 22x10-2 22x10' 0.044
Vinyl chloride 1 10000 1.3 x 10-6 7.7 x 10-' 7.7 x 102 0.013
'From Table If adoed fa ocapatiatal aqwstxe. Estirnaled risic b hanm kan epOSUe b a time-aeigtled
ayeape d 1 µphrr' br a
noma! 8-hau wakday. 40-1m workweelc 4anar career (see ie4.
contains the Iinternational Agency for Research on Cancer's
(IARC) classification of each of these chemicals.(1`') This
classification scheme evaluates the likelihood that these
chemicals are human carcinogens but makes no attempt
to quantify their potential risk or to set "safe" exposure
levels. Hexachlorobutadiene is classified by IARC in cate-
gory 3, "the agent is not classifiable as to its carcinogenicity
to humans:'t14> Seven other chemicals: acrylamide (2B),
acrylonitrile (2A), beryllium (2A),1,3-butadiene (2B), cad-
mium (2A), carbon tetrachloride (2B), chloroform (2B),
methylene chloride (dichloromethane) (2B), ethylene ox-
ide (2A), and formaldehyde (2A) are in IARC category 2,
"the agent is probably (2A) or possibly (2B) carcinogenic
to humans." The remaining five chemicals, benzene,
bis(chloromethyl) ether, chromium VI, nickel refinery dust
(nickel comlxiund5), and vinyl chloride are in IARC cate-
gory i "human carcinogens."
Using vinyl ~chloride as an example, Figure 2 illustrates
the typical relationship found between the dose-response
curve resulting from a QRA of the type performed by the
EPA, the empirical data on wh;.:i the modeling is per-
formed, and the TLV established by the ACGII 1. The slope
of the dase-response curve shown here (i.e., 0.0013) is
derived from ihe EPA unit risk factor for vinyl chloride
adjusted to reflect the exposure situation of the occupa-
tional environment.
Discussion
In this set of 16 chemicals, both the EPA and the ACGIH
approaches r,tnk them in approximately the same order
of carcinogenic risl:. However, the EPA is far more con-
servative, refle(aing the agency's objective to piotect all
members of the community, not just healthy adults. The
authors could ;not definitively comment on the relative
accuracy of the two approaches because our theoreticall
understanding of the dose-response relationship for oc-
cupational carcinogens is still elementary, and we are,
therefore, limited in our ability to discriminate between
the accuracy of the'ILV and QRA approaches. One is further
hampered by the fact that the empirical data available to
assess the carcinogenicity of specific chemicals are usually
the result of animal experiments at high doses, together
with a battery of short-term tests which are sometimes
augmented by epidemiology studies that usually have scanty
exposure information. The available occupational cohort
studies have not followed workers for their entire lifetime
and, thus, do not give complete inforntation on agents
which cause cancer many years after exposure. Conse-
quently, no one at the present time can speak with scientific
certainty about "safe" levels of exposure to carcinogens.
Although decisions on the perrnissible exposure to car-
cinogens are fraught with difficulty, we believe that rec-
ommending maximum levels of occupational exposure
should be guided by three principles:
1. Scientifically, one should seek the most appropriate
data and methnds for predicting the effect of human
exposure to carcinogens based on our latest theo-
retical understaaditt¢; of the prooess of carcinogenesis.
2. As a public health issue, one should admit the im-
precision of our knowledge and compensate for our
uncertainty by building into the system a margin of
safety.
3. As public policy, one should explicitly document the
methodology.
The increasing motivation to use QRA as a tool to es-
tablish occupational health standards dates from the 1980
decision by the Supreme Court to overturn the Occupa-
tional Safety and Health Administratfon's (OSHA) newly
proposed benzene standard.0 5) The court maintained that
514 APPt- oCCUP. eW1NaVt PlYS. 3/t! A06tJSt 1990

OSHA ha,d failed to show a significant reductior in risk
going frc;m 10 to I ppm. Although OSHA did not propose
a fi>rmal policy in response to the decision, the agenn, has
generalhy accepted the view that quantitation of risk is
required for the regulation of carcinogens, and it has in-
Q-()rporated QRAs into its standard setting activitysince that
time.
A~iiitLst th.e controversy associated with modeling a pro-
cess th: is incompletely undersaxxi scientifically and the
judicial political climate which favors the use of a quan-
titative procedure to help regulate carcinogens in the gen-
eral environment and workplace, the EPA and other reg-
ulatony agencies have opted for the use of a conservative
approach in the development of risk assessment proce-
dures. For example, the QRAs are usually based on t;,e
most sensitive species and use of the most conservative
dose-response curve, while low weight is given to neg-
ative epidem iological data.~ 5) Although this procedure has
been criticized by some industry representatives(16) and
some academic scientists,07t it would be difficult to per-
form numerous risk calculations involving all plausible
options for the many judgments that must be made in the
development of a QRA. For most chemicals, this would
result in such a wide range of risk estimates that the anal-
vsis would not be u.seful to the regulatory agency or to
others formulating public policy. The CS-TLV Committee,
on the other hand, provides recommendations for the use
-3 -2
10 10
. rn9/m3
-1
10
10
0
of industrial hygienists rather than setting governmental
standards, and the Committee bases its recommendation
on the professional judgement of its members. Both the
TLVs and QRAs are subject to external reviews before
adoption.
With this perspective in mind, the authors compared the
chemical carcinogens which were quantitatively evaluated
by the two procedures. The first qualitative comparison is
that only 16 chemicals appear on both the CS-TLV Com-
mittee list and the EPA list. However, this apparent dis-
agreement is not too surprising because of the substantially
different mission of these two organizations and the ap-
proaches they take when classifying the hazardous "po-
tency" of chemicals. TLVs are quantitative guidelines for
recommended exposures in the workplace, hut there is
no explicit estimate of the health risk associated with these
leveLs. On the other hand, the EPA unit risk factor explicitly
relates dose to cancer risk by means of a mathematical,
linearized, multistage model of rarcinogenesis, but few
have been translated into pc rmissible exposure levels. Op-
erating as an independent organization, the IARC reviews
all relevant scientific information in order to assess the
evidence that an agent could alter the incidence of cancer
in humans but makes no attempt to extrapolate beyond
the range of the available data. Likewise, no recommen-
dation is given for safe exposure levels for regulation or
legislation.t t4/
1
10
10
2
3
10
concentration (tog scate)
10
It
10
5
FGURE 2. Comparison of TLV, EPA unit risk dose-response, and animal bioassay re.sufts for vinyl
cttlotide exposure.
APPL OCCUP. ENV78ON. NYG. 3/81 AUGUST 1990 515

The principal reason for this wide disparity between the
EPA and the CS-TLV Committee may be explained primarily
bv the underlying philosophical principles governing the
two organizations rather than the technical differences be-
tween the two methods. The CS-TLV Committee is gov-
erned hy the principle that "Threshold limit values refer
te~ airh<;rne concentrations of substances and represent
cUnditiUns under which it is believed that nearly all work-
ers ma%- he repeatedh exposed day after day without ad-
verse effect. Because of wide variation in individual sus-
ceptibiliiv, however, a small percentage of workers may
experience discomfort from some substances at concen-
trations at or below the threshold limit; a smaller per-
centage miy be affected more seriously by aggravation of
a pre-exi.sting condition or by development of an occu-
pational il;lness"11z> Use of the TLV for other purposes,
such as community air standards, is specifically discour-
aged by the Committee. Thus, the CS-TLV Committee rec-
ommendations imply that there is a small degree of risk
of occupat.ional illness to some workers who are more
susceptible than others.
The Clean Air Act, which in part governs EPA's approach
to performing QRAs, is more philosophically conservative.
The Act states that Primary Air Standards must protect the
public heal¢h with an adequate margin of safety based on
a review of air quality criteria which reflects the latest state
of scientific knowledge about the pollutant. The require-
ment for an "adequate margin of safety" is intended both
to address inconclusive scientific and technical information
and to provide a reasonable degree of protection against
hazards that: research has not ,vet identified Recognizing
that imposing zero emission for some substances would
impose too heavy an economic burden on society, EPA has
addressed tlle problem by proposing that the Best Avail-
able Technology (BAT) be used to control carcinogens. If
BAT controls leave an unreasonable residual risk, further
controls will be considered ! 17)
When making a quantitative comparison between the
ACGIH and the EPA approaches, substantial agreement is
found when classifying the relative potencies of these car-
cinogens, but substantial disparity in the actual levels pro-
posed or rec.omtnended Estimating lifetime cancer risks
from occupational exposure at the ACGIH's 'ILV levels by
using the EM's QRA model sometimes resulted in extraor-
dinarily high risk estimates, 68 percent from exposure to
1,3-butadiene and 19 percent from exposure to chloro-
form, which may reflect either limitations in the QRA mod-
eling approach or the TLV safety factor approach.
A safety /actor approach, such as that used by the CS-
TLV Committee, is theoretically no more or less conserv-
ative than a QRA approach which is linear at low doses
and assumes no threshold. In practice, however, use of a
safety factor of 5-10 or even 100-1000 is markedly less
conservative than the QRA approach which determines an
exposure level associated with a very small risk level such
as 1/1oc'. This p:)int is illustrated for vinyl chloride in Figure
2 which compares the EPA unit risk factor for the upper
confidence limit on the estimated human dose-response
with the TLV and the results of animal bioas.tiays. With no
attempt made to acknowledge the inconsistency produced
by these differing methcxis, confusion and skepticism have
resulted. Although there are strengths and weaknesses as-
sociated with the approach of each group, it would seem
that the CS-TL%' Committee could make a major contri-
bution to fostering control of carcinogens in the workplace
bk reviewing any available EPA QRA, or comparable mod-
eling data when it updates or establishes a new TLV for a
conlirmed or suspected human carcinogen. When possi-
ble, the CS-TLV Committee should also consider the results
of studies that use more refined modeLs for QRA Being
les,s constrained by the judicial-political climate than the
regulatory agencies, the CS-TLV Cotnmittee should be bet-
ter able to promptly adopt the most scientifically defensible
extrapolation procedures available when a particular
chemical is being studied in terms of recommended oc-
cupational exposure values.
Although many scientists remain skeptical about the pos-
sibility of extrapolating the effects of carcinogens to low
doses, a systematic evaluation of the results of these esti-
mates in future editions of the TLV Documentation volume
would help alleviate the confusion that now exists.
Referenees
1. Spirtas, R.; Steinberg, M.; Wands, RC.; Weisburger, EK: Identification
and Clmsification of Carcinogens Procedures of the Chemical Sub-
uancesThreshold timit Value Committee, ACGQ-I. Am.J. PubLc Health
76(10):1232-1235 (1985).
2. American Conference of Governmental ItAtstrial Hygienists: Thresh- '
old Limit Values for Chemical Substances Biotogical Exposure Indices
for 1989-1990. ACGIH, Cmcinnui, OH (1989).
3. U.S. Environmental Protection Agesx.y: Respondans brief in support
of propevied findings, catcfusions and order at 63-64, in re-. Stevens
tndtntry, Inc (Consotidued DJT Hearings), Agril 5, 1972.
4. U.S. Environmental Pnoteaiat Agency: Respondents motion to de-
termine wltether or not the negistratiotis of mhrx should be canceled
cx amenafed; Attachment A, September 5, 1975.
5. U.S. Environmental Protection Agesxp: lnoerim Procedures and
Guidelines for lealth Risk and Economic lmpoct Asewtents of Sas-
pected Cardnogem Fed- Reg. 41:21402-21405 (1976).
6. Office of Science and Tecimoiogy: Policy on: Qtanial Carcittogenr
A Review ofthe Scieneeand itsAssociMedPrindpals. Fed. Reg 50:10372-
10442(Febrtnty 19B5k
7. xatkx>at Research Courtcit: Risk Aneswmt in the Federal Govertr
metu: iNaaagirg the Process. NatiotW t.ratlemy Ptess, Rashington DC
(1983).
8. Cauletrnn, B.L; Zietn, G.E.: Corpotate lulhxtaoe on Threshold limit
Vafte-s. Am. J. Ind. Med. 13:531-559 (1968)-
9. Andersen, M.E: Qu7¢vtiu&ve Risk AssewweM mtd Occvpational Car-
cino~ Appl. ind Hyg. 3(l0}267-272 (1964
10. Comlie4d, J_ Carcinogenic Risc Assessz~ Science 19&693--b49 (1977).
11. M<x>Jgavkar, S.FL; Knudson, Jr., AG.: lAtxuion and Cancer: A Model
for Hurmn Cucinoget>ests. J. Natl. Cx-scer Itffit. 66:1037-1052 (1961).
12_ American Conference of C'iowertutient IndssttW fiygicnist: 74trestroid
Limit Values and Biological Exposure Indices for 1967-1988. ACGIH,
Cincinnati, OH (1967).
13. U S. Environmental Protection Agetxy: Integnted Risk Infam=ion
System. EPN600V8-86/0321 Office of Health and Envim.urterual As-
s~xr~t Us Environrnerual Protet.~tion Agency, Washagton, DC (1987).
14. tnternaticxtal Agency for Research on Csneer: Overall Evsluxions of
Careinogenicity, Suppi. F. An Updatiag of IARC!<4onographs Volumes
1 to 42. JARC, Lyon, France (Mardi 1987).
516 APPL OCCUP. EiWIROM NYG. 50 . AUGUST 1990

Ii. Supreme Qturt of the United States: Industrial Union Depanment,
AFl: CIO v. American Petroleum Institute. et al., argued October 10.
19'9. dee:ided July 2. 1980. No. .'8-911. Washington, DC (1980).
IG. Anierican Industrial Health Council: Q mment on: A Rep ut < f the
GueraKenq- Regulatory Liaix>n Group Entitled ':ticientific Ba.u~ for
Ielentif}inK Potential Carcinogens and Estimating their Ri,k." AIHC.
"iar.uLle. ( btay S. 19-9 ).
17. Purchase, LF.: Inter,pecies Compari.xxts of Carcinogenicity. Br. J.
Cancer 41:454-46K (19ki0).
18. l'.S. EmOronmerttal Protection Agency: Policy and Procedures for
IdentiF<ing, and A,sessinR and Regulating Airtx)rne Substances Pc .tiinR
a Risk of Cancer. Pr<tpu ecl Rule Fed. Reg. a4:5£3(i42 (19t30).
Received 8 28r89: review decision 12/t/89; revision 2/8190; accepted 3/9/90
APPL OCCUP. ENVIRON. HYG. 5/8) AUGUST 1990 517
